Rebecca Wright12.01.08
"With the most historic election of our time behind us and a winner declared, dietary supplements and functional foods will likely enter a new period of regulatory scrutiny as the Democrats take firmer control of Congress. The good news is a large number of companies are already taking steps to prepare for this new era of enforcement, thanks to new dietary supplement GMPs and mandatory adverse event reporting requirements. The other good news? There seems to be overwhelming support for the health and wellness industries from President-elect Barack Obama, who himself is a health and fitness enthusiast. In fact, his healthcare plan echoes many of the sentiments voiced by this industry's pundits at one time or another. The Obama-Biden healthcare plan specifically states: 'Our healthcare system has become a disease care system, and the time for change is well overdue.' My long-term view is that President-elect Obama will see this industry and its products as part of the country's healthcare solution, regardless of what happens on the regulatory and economic fronts."-Rebecca Wright, Editor
"2008 became the year of the wavering hand. Financial belt tightening at the very personal level forced many people to make a 'this one-that one' choice between the brand they had come to trust and the 'house' brand of the same vitamin, mineral, botanical or dietary supplement. The enactment of dietary supplement GMPs in 2007 forced contract manufacturers to meet higher standards, and in doing so, assured retail chains that they could stand behind copycat products they brought to market. That trend will continue in 2009.
"And targets will change. Under 'because that's where the money is,' Pfizer recently announced changes in its strategic direction for drug development-discontinuation of development for heart disease, obesity and bone health, and instead a focus on Alzheimer's disease, diabetes, pain relief, inflammation/immunology and cancer. The supplement and functional food industry should follow suit, especially for age-related loss of mental performance and Alzheimer's disease. Call it 'No brain left behind.'"-David Mark, PhD, Founder, dmark consulting LLC
"The economic situation should negatively impact the sales of natural and organic products during the next calendar year. Retail prices should be reduced because consumers will be much more price conscious, and organizations can compensate for lower margins by maintaining volume due to the price reductions. Raw material costs are likely to increase, profit margins will be squeezed, and return on investment will fall. Most experts are predicting the worst holiday season in decades. This means that decision-makers should revise revenue and profit objectives to incorporate the current and projected economic reality, and look for ways to reduce costs through sustainability initiatives."-Darrin Duber-Smith, President, Green Marketing, Inc., and Visiting Assistant Professor of Marketing, Metropolitan State College
"I think most companies experienced steady business conditions in 2008 and would be relieved to see a repeat in 2009. Certain categories, such as digestive products and omega fatty acids remain bright spots, posting above average growth. Based on recent economic conditions, however, we may see consumers switching from their favorite branded supplements to less expensive private label products. Xsto will bring to market a number of key high quality, value-based ingredients to help our marketing and manufacturing partners take advantage of this switch."-Dan Murray, Vice President, Business Development, Xsto Solutions
"No mention of the state of the supplement industry is complete without noting the first FDA GMP compliance date and the start of mandatory reporting for serious adverse events by industry to FDA. AHPA has established interim guidance for heavy metal limits in herbal supplements, something USP is at work developing. Other indications of continued progress include NCCAM's new director Josephine Briggs, MD, taking that NIH center on a botanical research path emphasizing basic discoveries prior to large clinical trials. Also, AOAC will continue analytical method development and NIST will make reference materials using NIH Office of Dietary Supplement funding."-Steven Dentali, Chief Science Officer, American Herbal Products Association (AHPA)
"As an ingredient supplier, 2008 was the most impactful and dynamic I have witnessed. The changing landscape was affected in a number of ways. First, the bankruptcy of a major manufacturer (Leiner) caused tremendous financial turmoil in a sector of the market that already generally operates on relatively narrow margins. The acquisition of Leiner out of bankruptcy by NBTY quickly changed the balance of purchasing by consolidating two major customers into one. This consolidation of customers forced many ingredient suppliers to re-evaluate market positioning and pricing in an effort to maintain fiscal balance.
"Second, the weakening of the U.S. dollar put significant pressure on the importation of ingredients.
"Lastly, quality control, both internationally and domestically, was elevated to a higher level of awareness. Both product and process quality standards were re-evaluated because of consumer and industry requirements. Between the media and newly adopted GMPs, ingredient suppliers were put on notice that quality control was as much a part of the value of the product as the price."-Scott Steinford, President, ZMC-USA, LLC
"It's an election year and as of this writing the decision is not yet made. Whatever the outcome, the state of this industry is one of torpor. We are less concerned about government these days and are ignoring the other external threats. Still, there remains a petition with FDA that would yield a precedent of enormous proportions: The disallowance of a whole class of claims. The same external threat is revealed in combining drugs with dietary ingredients. Yet these two forays by the external forces are but probes, checking defenses. FDA is the respondent and not the threat. This coming year will begin to define FDA's role and interest in our industry as not seen this century. All as a result of the real external threat."- Jim Lassiter, President, The Lassiter Group
"In my mind, quality, in any industry, is a fundamental prerequisite for success. And the last 10 years have witnessed, if not a revolution, then certainly an evolution of dietary supplement quality. The decade began with media reports of sub-potent and adulterated products, which incited anxiety and frustration in consumers and industry alike. These same issues led NCCAM to create policy around the integrity of study materials and are the focus of NIH/ODS's Analytical Methods & Reference Materials Program. The long awaited cGMPs certainly have and will continue to play a role in this evolution as they come into full effect. I look forward to the growth of this industry in the coming years as the quality evolution continues." -Paula Brown, Director of the Natural Health Product Research Group (NRG) at the British Columbia Institute of Technology (BCIT)
"Naturex experienced tremendous growth in 2008, as consumers are increasingly looking for clean labeling and authenticity. We control all the stages of the manufacturing process, from raw materials to final extracts. Therefore it makes sense for us to make R&D, QC and fair trade our priorities. There are several challenges for the coming year, including: legislative issues, building consumer loyalty and developing more innovative products. Educating consumers on the health benefits of nutraceuticals remains among the top priorities. They are becoming more and more informed and they are making better use of that information. The ability to effectively communicate a specific health benefit associated with an ingredient will be, more than ever, a key way to gain a significant share of the market. Herbal categories for cognitive performance, weight loss and diabetes will grow steadily. The sheer number of people turning to herbs will push the category very far.
"In addition, Naturex is truly involved in sustainability and corporate responsibility. We have upgraded to an upper level in 2008 with the opening of our own Corporate Foundation. The Naturex Foundation supports education medicine and basic necessities in communities from which Naturex derives plant materials, outside of any economic interest."-Antoine Dauby, Group Marketing Manager, Naturex Inc.
"As I write this, the industry has just returned from the Expo East and Supply Side West shows, where talk was of the struggling economy and the presidential race. By the time you read this, we'll know who the next president is and the economy-hopefully-will have stabilized somewhat. The volatility of 2008 made it a cautious year for the nutraceuticals industry, with many companies holding back on new investments or expansions, focusing on holding onto existing market share in a world where food prices are rising and discretionary spending dollars are falling. As we look ahead to 2009, there are still bright spots-omega 3's, probiotics, possibly stevia-as well as emerging technologies that could drive the industry of the future. However, the lack of financial support for these early stage ventures does not bode well for a successful long-term future. Let's hope investors and forward-thinking companies alike see the value of new product development supported by scientific research so the industry of 10-20 years from now will continue to achieve success."-Ellen Schutt, President, Schutt Solutions
"At this time (early November 2008) it is not possible to foresee the effects of what appears to be a global economic downturn on the performance of the herb and dietary supplement industry in the U.S. and beyond.
"For the domestic market, from a supply-side perspective, it is well known that a significant portion of the raw materials used in dietary supplements are sourced from outside the U.S. As credit tightens and cash is increasingly scarce, it is probably safe to predict that numerous suppliers will not be able to hold adequate inventories to meet current demand and/or be able to fill existing orders.
"The big question is on the demand side: How will this past summer's $4+/gallon gas prices and the rising costs of foods and other nondurable consumer goods impact the budgets of consumers' purchases of dietary supplements? In past periods of economic downturn, the herb and dietary supplement segments performed fairly well, suggesting that consumers place a relatively high priority on supplements and are willing to continue using them as an integral part of a healthy lifestyle. It is still too early to determine definitively how the current global economic and credit crisis, and the general state of anxiety it has produced among consumers, the financial sector, government officials, the media, et al. will affect consumers' perceptions of dietary supplements, i.e., whether they will be seen as integral or expendable in lieu of other priorities.
"The answer may be both. That is, for what the marketing experts call the 'core consumers,' herbs and other dietary supplements will probably continue to be seen as integral and of high priority. Hopefully, demand from this segment will continue without any serious declines. However, to the so-called 'peripheral shopper,' various supplements may be seen as an expendable luxury, being trumped by necessities like conventional foods, gas, rent or mortgage payments. In this market segment, a falloff in demand may be imminent. Hopefully, this scenario will not materialize, but consumer purchasing shifts have already suggested this may become part of the new status quo."-Mark Blumenthal, Founder & Executive Director, American Botanical Council, and Editor, HerbalGram & HerbClip
"2008 has been one of our strongest years in both the North American market and abroad. As companies continue to push toward GMP compliance, there is an increasing demand toward certifying their GMP programs with an ANSI accredited third party. In addition to seeing an increase in GMP certifications, we have also seen business grow in areas of supply chain security and certification for ingredient suppliers. Due to the growing demand of this sector of the industry, we have opened a new office in Thailand, and have expanded our service offerings through our offices in China, India and Europe, for which we anticipate continued growth for these programs and services into 2009."-Edward Wyszumiala, General Manager, Dietary Supplement Programs, NSF International
"The biggest story of 2008 is the accelerating pace of the formulation of nutraceuticals into functional foods. Beverages and dairy products are the leading delivery vehicles, but consumers' appetite for more natural and clinically demonstrated healthy ingredients in their foods has become a mainstream driving force for new product development and product line extension. Another category newly emerging in North America is nutricosmetics, where nutraceuticals offering 'beauty from within' are grabbing much media attention, to be hopefully followed by sales. Further, the 'Health and Wellness Paradigm' is being presented as a key component in addressing healthcare and sustainability."-Paul Flowerman, President, P.L. Thomas & Co., Inc.
"The key areas worthy of attention in the next year for the dietary supplement industry are: Congressional meddling in oversight and potential legislation; FDA enforcement of the new GMPs for dietary supplement manufacturing; discussions about serious adverse events reports now mandated by Federal law; continued concerns regarding supply chain quality from foreign sources; and the implications of reduced credit availability and the increasing value of the U.S. dollar against foreign currencies.
"If there was ever a time to be operationally nimble, politically adroit and free of substantial debt burdens, this is it."-Mark LeDoux, Chairman & CEO, Natural Alternatives International, Inc., and Chairman-elect, Council for Responsible Nutrition (CRN)
"Fears are high that the global economic crisis and credit crunch will have a chilling effect on new product development in the nutraceutical and functional foods markets. It remains to be seen how consumers' discretionary spending for these products will be affected by tough financial times. Nevertheless, forward-thinking executives in these industries still regard innovation as the engine of growth, and it is more needed than ever to guard against market losses. Hopefully, we will also walk away with the lesson that exporting our manufacturing jobs and ingredients business to China was not in the best interest of the economy here at home."-Jeremy Appleton, Technical Marketing Manager, Nutrition, EMD Chemicals
"It's a great time to be in the business of nutritional ingredients, as studies continue to show the importance of particular nutritional ingredients on health. Consumer demand for nutritional solutions to health concerns has grown and nutrigenomics is actually becoming reality. For instance, researchers have shown that fermentation of natural resistant starch turns on genes within the large intestine-increasing the production of satiety hormones GLP-1 and PYY, as well as changing the expression of cancer-related genes. I look forward to the near future, in which personalized medicine, based not only on one's DNA, but also dietary interactions between nutritional ingredients and genes becomes more understood and utilized."-Rhonda Witwer, Senior Business Development Manager, Nutrition, National Starch Food Innovation
"The industry is faced with some short-term antagonism due to the whole foods movement led by author Michael Pollan and his insistence that reductionism ruins the health of food. If we were to follow this thinking, it would prevent the isolation and characterization of beneficial bioactives, which we then add back to foods-clearly not where we want to go for the health of our citizens. This challenge simply means we must concentrate even more on science so consumers are assured of the effectiveness of the products they buy and see results from consuming them. If we don't do this, then the industry will simply drift along and never reach the potential growth that is so blithely predicted."-Fergus Clydesdale, PhD, Distinguished Professor & Head of the Department of Food Science, University of Massachusetts, Amherst
"2008 was an average year until the fourth quarter, which shook every industry regardless of their activities. As a result, companies will be trying to get back to basics in 2009. Everyone has scaled back plans and high priced items are tougher than ever to sell. Based on this last quarter, customers large and small will be looking for value and that will be required throughout the whole supply chain, from ingredient suppliers to manufacturers, and ultimately consumers. For the future, no one segment stands out in terms of above average growth, although this could be influenced by new science that comes out supporting a particular ingredient or category."-Brian Stagg, New Business Development-North America, Diana Naturals
"The past year has been an exciting one for Albion. It has been a year of expansion for our market base due to the EFSA (European Food Safety Authority) approval of Albion's Mineral Glycinate Chelates, which will allow sales of Albion's U.S.-made materials to grow throughout the EU, thus pioneering the way for chelates into this market. In addition, Albion has improved its ability to go after the U.S. food and beverage market via an expansion of our list of GRAS mineral ingredients. Although the U.S. economy has sagged, we feel that the U.S. nutraceutical market has remained strong, and will stay so. The global expansion of U.S. companies in the nutraceutical business will also continue, furthering the maturation of our industry. Continuous improvement in our standards will help ensure we can meet the regulatory requirements in all parts of the world. In 2009, companies that push for more clinical research and higher quality standards will prosper."-Max Motyka, MS, RPh, Director of Sales & Marketing, Albion Human Nutrition
"This year observed more interest and concern regarding the safety of dietary supplements and functional foods, in part from perceived and real defects in ingredient quality. 2008 also brought the implementation of two major initiatives in the regulatory arena: new mandatory Adverse Event Reporting and cGMPs specifically suited for dietary supplements. Public documentary standards and compendial reference materials may serve as valuable resources for manufacturers and regulators in setting the private specifications and calibrations required by the GMP Rule. In the future, 2008 will be remembered as an inflection point in manufacturing practices, bringing increased acceptance and trust in manufacturers' offerings."-James Griffiths, PhD, Vice President of Food & Dietary Supplement Standards, U.S. Pharmacopeial Convention (USP)
"Despite the fact that irradiation and ETO of botanical raw materials is clearly no longer allowed, some manufacturers continue to operate in defiance of the law. These companies are not only putting their own reputation at risk, but they are also damaging the reputation of the entire industry, as well as potentially endangering their customers. One of BI Nutraceuticals' goals in 2009 is to continue to educate the industry about safe and effective alternatives for sterilizing raw materials, most notably steam sterilization. BI has spent 10 years perfecting Protexx HP, the industry's only species-specific, organic steam sterilization method. This GMP-compliant sterilization system uses super-heated dry steam to reduce microbiological load with results comparable to that of treatment with ETO or irradiation, without the potential regulatory issues. Protexx HP is a completely natural, environmentally friendly sterilization process that is also certified organic by Quality Assurance International. Additionally, Protexx HP not only meets, but also exceeds the new dietary supplement GMP regulations. It is definitely a smart and safe sterilization alternative for responsible manufacturers and marketers."-George Pontiakos, President & CEO, BI Nutraceuticals
"Wellness and sustainability must go hand in hand as we strategize for the future. Cognis develops innovative products based on renewable raw materials that combine top performance with superior sustainability credentials. In addition, considering the global economic challenges, we must work even harder to make sure consumers understand the benefits and value inherent in dietary supplements and functional foods. Education is fundamental to ensuring that consumers are confident in their buying decisions, knowing that their products are safe and backed by credible science. Demand will continue to escalate for natural ingredients and Cognis is well positioned with our broad portfolio of products, including Covitol natural vitamin E, Betatene natural mixed carotenoids, Heart-Choice natural phytosterols, Xangold natural lutein esters, and Omevital omega 3 fatty acids. Branded ingredients have been proven to build trust and loyalty among consumers and this trend is certain to continue as we are finding with Cognis' Tonalin CLA."-Dave Eckert, Vice President, Cognis Nutrition & Health
"Difficult economic times have made finding growth opportunities in today's marketplace challenging. But even in a difficult market there are consumer needs to be met and opportunities to pursue. Consumers are becoming more aware of the benefits of a healthy lifestyle and will continue to seek support from functional food and beverages and dietary supplements for their health concerns-including weight management, blood sugar control and joint health problems. High quality, effective and safe ingredients that provide substantial health benefits increase consumer value, differentiate products and secure competitive advantage in today's troubled market. InterHealth offers high-quality, well-researched branded ingredients that meet the needs of today's discerning consumer, including Super CitriMax for weight management, UC-II for joint care and ChromeMate for cardiovascular health and blood sugar control."-Paul Dijkstra, CEO, InterHealth Nutraceuticals, Inc.
"I think the natural and organic industry is definitely retrenching in 2008 as a result of the lagging economy, as well as a slowdown in new product and new technology development. There is a much more conservative tone in the industry currently, as many companies prefer to play it safe and wait for the storm to pass. That said, others are gearing up for major launches in 2009, investing money now to reap the benefits as the market rebounds. It's the classic question of whether or not you should continue to promote in a down economy. While most research says that companies that spend in tough times benefit in both the short and long term, that philosophy may be hard for some companies to embrace. One noticeable shift in the market is a move toward more innovative dosage and delivery forms. Traditional tablets and capsules are making way for gels, liquids, strips, gummies, tear pouches and chews. Some may call it 'borrowed interest,' but it certainly helps create some excitement and energy for a brand. Time will tell."-Jeff Hilton, President, IMG
"Due to today's suffering economy and high cost of health foods, food and beverage manufacturers, more than ever, are looking for a special edge to help move their products off the shelves. Each package needs to have the right key words printed on them, and each product needs to contain the right ingredients. Manufacturers will have to move away from just printing 'Fortified with Omega 3' and specifically label which type of omega 3 the product is fortified with. DHA omega 3 will be the clear front runner, beating out ALA and EPA, which offer less as a functional ingredient."-Tony Martin, Public Relations Specialist, Martek Biosciences Corporation
"Vitamins, carotenoids (beta-carotene, lycopene, lutein) and omega 3s are the most popular health ingredients, which are being consumed by a global aging population more than ever. In general, product safety and traceability have become big issues in the nutrition market along the entire value chain. The latest food scandals (e.g. the melamine case) have provided clear evidence that sustainable success can only be achieved with excellent quality products and reliable traceability on a global scale. Eco-efficient and sustainable production of health ingredients is another area of growing importance. For the future, excellent product features should include: premium formulations, high stability and scientifically proven health benefits. And guaranteed compliance with the highest safety and transparency standards will be crucial for the success of any player in this global market. As a trustworthy supplier, BASF Nutrition Ingredients is offering the 'brand value insurance' the food and dietary supplement industry is looking for."-Dr. Martin Jager, Group Vice President, GBU Nutrition Ingredients, BASF SE
"Americans are finding themselves having to cope with abnormally high levels of stress. Whether it's the uncertain economic future, the skyrocketing costs of everything from food to oil, or the recently contentious presidential election, Americans are more stressed out. It is no secret that increasing stress negatively impacts the body's immune system. At Embria, we are committed to demonstrating the importance of immune balance. With healthcare costs continually on the rise, maintaining a healthy immune system for prevention is important, and consumers will increasingly be looking to our industry for cost-effective, safe and preventative approaches to maintaining good health."-Paul Faganel, President, Embria Health Sciences
"As we conclude 2008 and begin 2009 I would like to note several key industry trends. While there have been less new ingredient launches, the science on existing products and ingredients has been more robust. This is potentially helpful for industry credibility, but the downside is reduced growth and innovation. Going forward, there will be increased consolidation as larger companies acquire midsize and small companies in all levels of the industry, from ingredients and processing to marketing to retail. 'Diseasification' of wellness issues will reduce the number of allowable products and health claims. Further, the majority of manufacturing volume will be subject to federal GMPs this year. As for China, there will be a backlash as far as trust, prompting the desire to source elsewhere. Lastly, the global recession and credit crunch will most certainly negatively impact consumer demand and working capital for manufacturers."-Kenn Israel, Vice President, Marketing, Robinson Pharma Inc.
"Aloe vera, as an herb, has been referred to as 'old' and 'lacking excitement.' I agree that it has a reputation that goes back to ancient times. This means it has a proven record of safety of use greater than any other herb. Aloe vera remains the number one herb asked for by the consumer when purchasing natural products.
"Immunity is of high concern in today's consumer market, and aloe vera is a trusted and valued herb that can enhance the body's immune system. Improve USA produces a unique aloe dehydrated powder, DaltonMax700, which retains the natural components of the fresh leaf. The natural components of the aloe leaf that enhance the immune response are the large polysaccharides with a molecular weight average of 1M Dalton. University studies have shown these large polysaccharides are responsible for the modulation of the immune response and enhancing wound healing. The old herb is not boring, rather it is reliable and proven over the ages to aid us in combating many of the ailments that besiege us today."-Bill Pine, Vice President, Improve USA
"On the surface and to the individual unfamiliar with the industry, it would appear that the financial meltdown, coupled with concerns about climate change, food safety and other issues have built momentum to increase regulation, and put a damper on innovation. However, being that GMPs and AERs are in place, to ensure consumer confidence in the quality and safety of products, and coupling that with exciting research on vitamin D, for example, the industry has the opportunity to play a vital role as a cost-effective, economically and scientifically sound component of our nation's healthcare system."-Daniel Fabricant, Vice President, Scientific & Regulatory Affairs
"2008 has seen many interesting events in the regulatory arena, the most prominent of which is the forthcoming 2nd tier of the cGMP compliance. From a 'historical' perspective-over the last 40 years of active involvement in the dietary supplement/botanical industry-it appears the industry is finally reaching a level of maturity that is achieving 'critical mass' and hence permanent residence among the many successful business models in the public domain today. This success brings with it a level of responsibility and accountability that must be dealt with on a daily basis in producing a finished product, so that the public is not only confident in its inherent safety, but also its quality and/or efficacy.
"Looking back at 2008, I am very proud to be a part of such an exceptional industry. As quality control/quality assurance specialists focusing on natural products analysis, our observations lead us to believe that the situation is only getting better for the industry and the consumer. While these changes will affect the way we all do business, there is no question in my mind that these changes are essential for this industry to achieve the highest level of trust and confidence expected by the consumer, and as a direct consequence, sales will continue to blossom for decades to come."-Sidney Sudberg, DC, L Ac, RH (AHG), Founder, President & CEO, Laboratory Director, Alkemists Pharmaceuticals
"A good friend of mine once told me that if you are going to be poor, you might as well be healthy. This reminded me that the industries that tend to survive in tough economic conditions are the ones that provide the essential simple pleasures of life. We go to the movies to forget about our daily problems, and we drink, smoke and gamble in order to cope with our daily lives. Wealth Daily writes, 'Tough economic times won't stop gamblers from gambling, drinkers from drinking, or smokers from smoking. It's not going to happen. In fact, tough economics may give them more reason to indulge in smokes, drinks, and gambling-the catalysts for 'sin' stocks.' As I thought more about my friend's comment, it became clear to me that smoking, drinking and gambling are not as popular as they used to be.
"I believe our industry has the potential to provide many of the simple pleasures that are affordable to everyday consumers. This can be accomplished by stepping up our product offerings to deliver the benefits of health, happiness and affliction independence.
"Izaak Walton once said, 'Look to your health; and if you have it, praise God, and value it next to a good conscience; for health is the second blessing that we mortals are capable of; a blessing that money cannot buy.'"-Paul Paslaski, Market Development Director, Cargill
"Is the omega 3 supplement market recession proof? Who would have thought to ask that question 12 months ago? Consumers taking omega 3 supplements do so because they understand the need for these fatty acids for optimum health and well-being. While we are all likely to feel the recession in our pockets, health and well-being will not be the first on the list to take the hit. I don't believe the omega 3 market is recession proof. However, I do believe it is recession resistant. Spending will tighten, but not at the expense of our health. The growing number of American consumers taking omega 3 supplements do so based on the vast number of clinical papers showing the necessity for these fatty acids to maintain a healthy life. Omega 3s are not a fad; they are vital for optimum health, well-being and happiness."-David Shannon, Sales Director-Health Care, Croda Inc.
"The events of the past several weeks on Wall Street and the procedures set in motion by the federal government are going to have a dampening effect on most sectors of the U.S. economy and indeed the entire world economy. Already we are seeing signs of belt-tightening within the pharmaceutical industry, with layoffs predicted in our leading research oriented companies. This does not bode well for the nutraceutical sector. Even though the credit crunch, which seemed ominous, has receded into the background, the real test is the upcoming shopping season with many retailers already dropping hints of tough times ahead for inventory control and cash flow. The silver lining in this scenario is the 100-day honeymoon traditionally granted to an incumbent new President of the U.S. Cautious optimism and easing credit problems could provide a nice bounce in the first quarter of 2009.
"The nutraceutical industry, however, continues to show its resilience in the middle of this doomsday scenario. The recently concluded Supply Side West show in Las Vegas was very well attended and upbeat. Brisk business was conducted on both days. One minor concern to many in our industry is the proposal being tabled to make obesity a clinical problem. We should vigorously defend against this proposal."-Jith Veeravalli, President, Gencor Pacific
"Safety appeared to be the critical issue this year, much more so c
"2008 became the year of the wavering hand. Financial belt tightening at the very personal level forced many people to make a 'this one-that one' choice between the brand they had come to trust and the 'house' brand of the same vitamin, mineral, botanical or dietary supplement. The enactment of dietary supplement GMPs in 2007 forced contract manufacturers to meet higher standards, and in doing so, assured retail chains that they could stand behind copycat products they brought to market. That trend will continue in 2009.
"And targets will change. Under 'because that's where the money is,' Pfizer recently announced changes in its strategic direction for drug development-discontinuation of development for heart disease, obesity and bone health, and instead a focus on Alzheimer's disease, diabetes, pain relief, inflammation/immunology and cancer. The supplement and functional food industry should follow suit, especially for age-related loss of mental performance and Alzheimer's disease. Call it 'No brain left behind.'"-David Mark, PhD, Founder, dmark consulting LLC
"The economic situation should negatively impact the sales of natural and organic products during the next calendar year. Retail prices should be reduced because consumers will be much more price conscious, and organizations can compensate for lower margins by maintaining volume due to the price reductions. Raw material costs are likely to increase, profit margins will be squeezed, and return on investment will fall. Most experts are predicting the worst holiday season in decades. This means that decision-makers should revise revenue and profit objectives to incorporate the current and projected economic reality, and look for ways to reduce costs through sustainability initiatives."-Darrin Duber-Smith, President, Green Marketing, Inc., and Visiting Assistant Professor of Marketing, Metropolitan State College
"I think most companies experienced steady business conditions in 2008 and would be relieved to see a repeat in 2009. Certain categories, such as digestive products and omega fatty acids remain bright spots, posting above average growth. Based on recent economic conditions, however, we may see consumers switching from their favorite branded supplements to less expensive private label products. Xsto will bring to market a number of key high quality, value-based ingredients to help our marketing and manufacturing partners take advantage of this switch."-Dan Murray, Vice President, Business Development, Xsto Solutions
"No mention of the state of the supplement industry is complete without noting the first FDA GMP compliance date and the start of mandatory reporting for serious adverse events by industry to FDA. AHPA has established interim guidance for heavy metal limits in herbal supplements, something USP is at work developing. Other indications of continued progress include NCCAM's new director Josephine Briggs, MD, taking that NIH center on a botanical research path emphasizing basic discoveries prior to large clinical trials. Also, AOAC will continue analytical method development and NIST will make reference materials using NIH Office of Dietary Supplement funding."-Steven Dentali, Chief Science Officer, American Herbal Products Association (AHPA)
"As an ingredient supplier, 2008 was the most impactful and dynamic I have witnessed. The changing landscape was affected in a number of ways. First, the bankruptcy of a major manufacturer (Leiner) caused tremendous financial turmoil in a sector of the market that already generally operates on relatively narrow margins. The acquisition of Leiner out of bankruptcy by NBTY quickly changed the balance of purchasing by consolidating two major customers into one. This consolidation of customers forced many ingredient suppliers to re-evaluate market positioning and pricing in an effort to maintain fiscal balance.
"Second, the weakening of the U.S. dollar put significant pressure on the importation of ingredients.
"Lastly, quality control, both internationally and domestically, was elevated to a higher level of awareness. Both product and process quality standards were re-evaluated because of consumer and industry requirements. Between the media and newly adopted GMPs, ingredient suppliers were put on notice that quality control was as much a part of the value of the product as the price."-Scott Steinford, President, ZMC-USA, LLC
"It's an election year and as of this writing the decision is not yet made. Whatever the outcome, the state of this industry is one of torpor. We are less concerned about government these days and are ignoring the other external threats. Still, there remains a petition with FDA that would yield a precedent of enormous proportions: The disallowance of a whole class of claims. The same external threat is revealed in combining drugs with dietary ingredients. Yet these two forays by the external forces are but probes, checking defenses. FDA is the respondent and not the threat. This coming year will begin to define FDA's role and interest in our industry as not seen this century. All as a result of the real external threat."- Jim Lassiter, President, The Lassiter Group
"In my mind, quality, in any industry, is a fundamental prerequisite for success. And the last 10 years have witnessed, if not a revolution, then certainly an evolution of dietary supplement quality. The decade began with media reports of sub-potent and adulterated products, which incited anxiety and frustration in consumers and industry alike. These same issues led NCCAM to create policy around the integrity of study materials and are the focus of NIH/ODS's Analytical Methods & Reference Materials Program. The long awaited cGMPs certainly have and will continue to play a role in this evolution as they come into full effect. I look forward to the growth of this industry in the coming years as the quality evolution continues." -Paula Brown, Director of the Natural Health Product Research Group (NRG) at the British Columbia Institute of Technology (BCIT)
"Naturex experienced tremendous growth in 2008, as consumers are increasingly looking for clean labeling and authenticity. We control all the stages of the manufacturing process, from raw materials to final extracts. Therefore it makes sense for us to make R&D, QC and fair trade our priorities. There are several challenges for the coming year, including: legislative issues, building consumer loyalty and developing more innovative products. Educating consumers on the health benefits of nutraceuticals remains among the top priorities. They are becoming more and more informed and they are making better use of that information. The ability to effectively communicate a specific health benefit associated with an ingredient will be, more than ever, a key way to gain a significant share of the market. Herbal categories for cognitive performance, weight loss and diabetes will grow steadily. The sheer number of people turning to herbs will push the category very far.
"In addition, Naturex is truly involved in sustainability and corporate responsibility. We have upgraded to an upper level in 2008 with the opening of our own Corporate Foundation. The Naturex Foundation supports education medicine and basic necessities in communities from which Naturex derives plant materials, outside of any economic interest."-Antoine Dauby, Group Marketing Manager, Naturex Inc.
"As I write this, the industry has just returned from the Expo East and Supply Side West shows, where talk was of the struggling economy and the presidential race. By the time you read this, we'll know who the next president is and the economy-hopefully-will have stabilized somewhat. The volatility of 2008 made it a cautious year for the nutraceuticals industry, with many companies holding back on new investments or expansions, focusing on holding onto existing market share in a world where food prices are rising and discretionary spending dollars are falling. As we look ahead to 2009, there are still bright spots-omega 3's, probiotics, possibly stevia-as well as emerging technologies that could drive the industry of the future. However, the lack of financial support for these early stage ventures does not bode well for a successful long-term future. Let's hope investors and forward-thinking companies alike see the value of new product development supported by scientific research so the industry of 10-20 years from now will continue to achieve success."-Ellen Schutt, President, Schutt Solutions
"At this time (early November 2008) it is not possible to foresee the effects of what appears to be a global economic downturn on the performance of the herb and dietary supplement industry in the U.S. and beyond.
"For the domestic market, from a supply-side perspective, it is well known that a significant portion of the raw materials used in dietary supplements are sourced from outside the U.S. As credit tightens and cash is increasingly scarce, it is probably safe to predict that numerous suppliers will not be able to hold adequate inventories to meet current demand and/or be able to fill existing orders.
"The big question is on the demand side: How will this past summer's $4+/gallon gas prices and the rising costs of foods and other nondurable consumer goods impact the budgets of consumers' purchases of dietary supplements? In past periods of economic downturn, the herb and dietary supplement segments performed fairly well, suggesting that consumers place a relatively high priority on supplements and are willing to continue using them as an integral part of a healthy lifestyle. It is still too early to determine definitively how the current global economic and credit crisis, and the general state of anxiety it has produced among consumers, the financial sector, government officials, the media, et al. will affect consumers' perceptions of dietary supplements, i.e., whether they will be seen as integral or expendable in lieu of other priorities.
"The answer may be both. That is, for what the marketing experts call the 'core consumers,' herbs and other dietary supplements will probably continue to be seen as integral and of high priority. Hopefully, demand from this segment will continue without any serious declines. However, to the so-called 'peripheral shopper,' various supplements may be seen as an expendable luxury, being trumped by necessities like conventional foods, gas, rent or mortgage payments. In this market segment, a falloff in demand may be imminent. Hopefully, this scenario will not materialize, but consumer purchasing shifts have already suggested this may become part of the new status quo."-Mark Blumenthal, Founder & Executive Director, American Botanical Council, and Editor, HerbalGram & HerbClip
"2008 has been one of our strongest years in both the North American market and abroad. As companies continue to push toward GMP compliance, there is an increasing demand toward certifying their GMP programs with an ANSI accredited third party. In addition to seeing an increase in GMP certifications, we have also seen business grow in areas of supply chain security and certification for ingredient suppliers. Due to the growing demand of this sector of the industry, we have opened a new office in Thailand, and have expanded our service offerings through our offices in China, India and Europe, for which we anticipate continued growth for these programs and services into 2009."-Edward Wyszumiala, General Manager, Dietary Supplement Programs, NSF International
"The biggest story of 2008 is the accelerating pace of the formulation of nutraceuticals into functional foods. Beverages and dairy products are the leading delivery vehicles, but consumers' appetite for more natural and clinically demonstrated healthy ingredients in their foods has become a mainstream driving force for new product development and product line extension. Another category newly emerging in North America is nutricosmetics, where nutraceuticals offering 'beauty from within' are grabbing much media attention, to be hopefully followed by sales. Further, the 'Health and Wellness Paradigm' is being presented as a key component in addressing healthcare and sustainability."-Paul Flowerman, President, P.L. Thomas & Co., Inc.
"The key areas worthy of attention in the next year for the dietary supplement industry are: Congressional meddling in oversight and potential legislation; FDA enforcement of the new GMPs for dietary supplement manufacturing; discussions about serious adverse events reports now mandated by Federal law; continued concerns regarding supply chain quality from foreign sources; and the implications of reduced credit availability and the increasing value of the U.S. dollar against foreign currencies.
"If there was ever a time to be operationally nimble, politically adroit and free of substantial debt burdens, this is it."-Mark LeDoux, Chairman & CEO, Natural Alternatives International, Inc., and Chairman-elect, Council for Responsible Nutrition (CRN)
"Fears are high that the global economic crisis and credit crunch will have a chilling effect on new product development in the nutraceutical and functional foods markets. It remains to be seen how consumers' discretionary spending for these products will be affected by tough financial times. Nevertheless, forward-thinking executives in these industries still regard innovation as the engine of growth, and it is more needed than ever to guard against market losses. Hopefully, we will also walk away with the lesson that exporting our manufacturing jobs and ingredients business to China was not in the best interest of the economy here at home."-Jeremy Appleton, Technical Marketing Manager, Nutrition, EMD Chemicals
"It's a great time to be in the business of nutritional ingredients, as studies continue to show the importance of particular nutritional ingredients on health. Consumer demand for nutritional solutions to health concerns has grown and nutrigenomics is actually becoming reality. For instance, researchers have shown that fermentation of natural resistant starch turns on genes within the large intestine-increasing the production of satiety hormones GLP-1 and PYY, as well as changing the expression of cancer-related genes. I look forward to the near future, in which personalized medicine, based not only on one's DNA, but also dietary interactions between nutritional ingredients and genes becomes more understood and utilized."-Rhonda Witwer, Senior Business Development Manager, Nutrition, National Starch Food Innovation
"The industry is faced with some short-term antagonism due to the whole foods movement led by author Michael Pollan and his insistence that reductionism ruins the health of food. If we were to follow this thinking, it would prevent the isolation and characterization of beneficial bioactives, which we then add back to foods-clearly not where we want to go for the health of our citizens. This challenge simply means we must concentrate even more on science so consumers are assured of the effectiveness of the products they buy and see results from consuming them. If we don't do this, then the industry will simply drift along and never reach the potential growth that is so blithely predicted."-Fergus Clydesdale, PhD, Distinguished Professor & Head of the Department of Food Science, University of Massachusetts, Amherst
"2008 was an average year until the fourth quarter, which shook every industry regardless of their activities. As a result, companies will be trying to get back to basics in 2009. Everyone has scaled back plans and high priced items are tougher than ever to sell. Based on this last quarter, customers large and small will be looking for value and that will be required throughout the whole supply chain, from ingredient suppliers to manufacturers, and ultimately consumers. For the future, no one segment stands out in terms of above average growth, although this could be influenced by new science that comes out supporting a particular ingredient or category."-Brian Stagg, New Business Development-North America, Diana Naturals
"The past year has been an exciting one for Albion. It has been a year of expansion for our market base due to the EFSA (European Food Safety Authority) approval of Albion's Mineral Glycinate Chelates, which will allow sales of Albion's U.S.-made materials to grow throughout the EU, thus pioneering the way for chelates into this market. In addition, Albion has improved its ability to go after the U.S. food and beverage market via an expansion of our list of GRAS mineral ingredients. Although the U.S. economy has sagged, we feel that the U.S. nutraceutical market has remained strong, and will stay so. The global expansion of U.S. companies in the nutraceutical business will also continue, furthering the maturation of our industry. Continuous improvement in our standards will help ensure we can meet the regulatory requirements in all parts of the world. In 2009, companies that push for more clinical research and higher quality standards will prosper."-Max Motyka, MS, RPh, Director of Sales & Marketing, Albion Human Nutrition
"This year observed more interest and concern regarding the safety of dietary supplements and functional foods, in part from perceived and real defects in ingredient quality. 2008 also brought the implementation of two major initiatives in the regulatory arena: new mandatory Adverse Event Reporting and cGMPs specifically suited for dietary supplements. Public documentary standards and compendial reference materials may serve as valuable resources for manufacturers and regulators in setting the private specifications and calibrations required by the GMP Rule. In the future, 2008 will be remembered as an inflection point in manufacturing practices, bringing increased acceptance and trust in manufacturers' offerings."-James Griffiths, PhD, Vice President of Food & Dietary Supplement Standards, U.S. Pharmacopeial Convention (USP)
"Despite the fact that irradiation and ETO of botanical raw materials is clearly no longer allowed, some manufacturers continue to operate in defiance of the law. These companies are not only putting their own reputation at risk, but they are also damaging the reputation of the entire industry, as well as potentially endangering their customers. One of BI Nutraceuticals' goals in 2009 is to continue to educate the industry about safe and effective alternatives for sterilizing raw materials, most notably steam sterilization. BI has spent 10 years perfecting Protexx HP, the industry's only species-specific, organic steam sterilization method. This GMP-compliant sterilization system uses super-heated dry steam to reduce microbiological load with results comparable to that of treatment with ETO or irradiation, without the potential regulatory issues. Protexx HP is a completely natural, environmentally friendly sterilization process that is also certified organic by Quality Assurance International. Additionally, Protexx HP not only meets, but also exceeds the new dietary supplement GMP regulations. It is definitely a smart and safe sterilization alternative for responsible manufacturers and marketers."-George Pontiakos, President & CEO, BI Nutraceuticals
"Wellness and sustainability must go hand in hand as we strategize for the future. Cognis develops innovative products based on renewable raw materials that combine top performance with superior sustainability credentials. In addition, considering the global economic challenges, we must work even harder to make sure consumers understand the benefits and value inherent in dietary supplements and functional foods. Education is fundamental to ensuring that consumers are confident in their buying decisions, knowing that their products are safe and backed by credible science. Demand will continue to escalate for natural ingredients and Cognis is well positioned with our broad portfolio of products, including Covitol natural vitamin E, Betatene natural mixed carotenoids, Heart-Choice natural phytosterols, Xangold natural lutein esters, and Omevital omega 3 fatty acids. Branded ingredients have been proven to build trust and loyalty among consumers and this trend is certain to continue as we are finding with Cognis' Tonalin CLA."-Dave Eckert, Vice President, Cognis Nutrition & Health
"Difficult economic times have made finding growth opportunities in today's marketplace challenging. But even in a difficult market there are consumer needs to be met and opportunities to pursue. Consumers are becoming more aware of the benefits of a healthy lifestyle and will continue to seek support from functional food and beverages and dietary supplements for their health concerns-including weight management, blood sugar control and joint health problems. High quality, effective and safe ingredients that provide substantial health benefits increase consumer value, differentiate products and secure competitive advantage in today's troubled market. InterHealth offers high-quality, well-researched branded ingredients that meet the needs of today's discerning consumer, including Super CitriMax for weight management, UC-II for joint care and ChromeMate for cardiovascular health and blood sugar control."-Paul Dijkstra, CEO, InterHealth Nutraceuticals, Inc.
"I think the natural and organic industry is definitely retrenching in 2008 as a result of the lagging economy, as well as a slowdown in new product and new technology development. There is a much more conservative tone in the industry currently, as many companies prefer to play it safe and wait for the storm to pass. That said, others are gearing up for major launches in 2009, investing money now to reap the benefits as the market rebounds. It's the classic question of whether or not you should continue to promote in a down economy. While most research says that companies that spend in tough times benefit in both the short and long term, that philosophy may be hard for some companies to embrace. One noticeable shift in the market is a move toward more innovative dosage and delivery forms. Traditional tablets and capsules are making way for gels, liquids, strips, gummies, tear pouches and chews. Some may call it 'borrowed interest,' but it certainly helps create some excitement and energy for a brand. Time will tell."-Jeff Hilton, President, IMG
"Due to today's suffering economy and high cost of health foods, food and beverage manufacturers, more than ever, are looking for a special edge to help move their products off the shelves. Each package needs to have the right key words printed on them, and each product needs to contain the right ingredients. Manufacturers will have to move away from just printing 'Fortified with Omega 3' and specifically label which type of omega 3 the product is fortified with. DHA omega 3 will be the clear front runner, beating out ALA and EPA, which offer less as a functional ingredient."-Tony Martin, Public Relations Specialist, Martek Biosciences Corporation
"Vitamins, carotenoids (beta-carotene, lycopene, lutein) and omega 3s are the most popular health ingredients, which are being consumed by a global aging population more than ever. In general, product safety and traceability have become big issues in the nutrition market along the entire value chain. The latest food scandals (e.g. the melamine case) have provided clear evidence that sustainable success can only be achieved with excellent quality products and reliable traceability on a global scale. Eco-efficient and sustainable production of health ingredients is another area of growing importance. For the future, excellent product features should include: premium formulations, high stability and scientifically proven health benefits. And guaranteed compliance with the highest safety and transparency standards will be crucial for the success of any player in this global market. As a trustworthy supplier, BASF Nutrition Ingredients is offering the 'brand value insurance' the food and dietary supplement industry is looking for."-Dr. Martin Jager, Group Vice President, GBU Nutrition Ingredients, BASF SE
"Americans are finding themselves having to cope with abnormally high levels of stress. Whether it's the uncertain economic future, the skyrocketing costs of everything from food to oil, or the recently contentious presidential election, Americans are more stressed out. It is no secret that increasing stress negatively impacts the body's immune system. At Embria, we are committed to demonstrating the importance of immune balance. With healthcare costs continually on the rise, maintaining a healthy immune system for prevention is important, and consumers will increasingly be looking to our industry for cost-effective, safe and preventative approaches to maintaining good health."-Paul Faganel, President, Embria Health Sciences
"As we conclude 2008 and begin 2009 I would like to note several key industry trends. While there have been less new ingredient launches, the science on existing products and ingredients has been more robust. This is potentially helpful for industry credibility, but the downside is reduced growth and innovation. Going forward, there will be increased consolidation as larger companies acquire midsize and small companies in all levels of the industry, from ingredients and processing to marketing to retail. 'Diseasification' of wellness issues will reduce the number of allowable products and health claims. Further, the majority of manufacturing volume will be subject to federal GMPs this year. As for China, there will be a backlash as far as trust, prompting the desire to source elsewhere. Lastly, the global recession and credit crunch will most certainly negatively impact consumer demand and working capital for manufacturers."-Kenn Israel, Vice President, Marketing, Robinson Pharma Inc.
"Aloe vera, as an herb, has been referred to as 'old' and 'lacking excitement.' I agree that it has a reputation that goes back to ancient times. This means it has a proven record of safety of use greater than any other herb. Aloe vera remains the number one herb asked for by the consumer when purchasing natural products.
"Immunity is of high concern in today's consumer market, and aloe vera is a trusted and valued herb that can enhance the body's immune system. Improve USA produces a unique aloe dehydrated powder, DaltonMax700, which retains the natural components of the fresh leaf. The natural components of the aloe leaf that enhance the immune response are the large polysaccharides with a molecular weight average of 1M Dalton. University studies have shown these large polysaccharides are responsible for the modulation of the immune response and enhancing wound healing. The old herb is not boring, rather it is reliable and proven over the ages to aid us in combating many of the ailments that besiege us today."-Bill Pine, Vice President, Improve USA
"On the surface and to the individual unfamiliar with the industry, it would appear that the financial meltdown, coupled with concerns about climate change, food safety and other issues have built momentum to increase regulation, and put a damper on innovation. However, being that GMPs and AERs are in place, to ensure consumer confidence in the quality and safety of products, and coupling that with exciting research on vitamin D, for example, the industry has the opportunity to play a vital role as a cost-effective, economically and scientifically sound component of our nation's healthcare system."-Daniel Fabricant, Vice President, Scientific & Regulatory Affairs
"2008 has seen many interesting events in the regulatory arena, the most prominent of which is the forthcoming 2nd tier of the cGMP compliance. From a 'historical' perspective-over the last 40 years of active involvement in the dietary supplement/botanical industry-it appears the industry is finally reaching a level of maturity that is achieving 'critical mass' and hence permanent residence among the many successful business models in the public domain today. This success brings with it a level of responsibility and accountability that must be dealt with on a daily basis in producing a finished product, so that the public is not only confident in its inherent safety, but also its quality and/or efficacy.
"Looking back at 2008, I am very proud to be a part of such an exceptional industry. As quality control/quality assurance specialists focusing on natural products analysis, our observations lead us to believe that the situation is only getting better for the industry and the consumer. While these changes will affect the way we all do business, there is no question in my mind that these changes are essential for this industry to achieve the highest level of trust and confidence expected by the consumer, and as a direct consequence, sales will continue to blossom for decades to come."-Sidney Sudberg, DC, L Ac, RH (AHG), Founder, President & CEO, Laboratory Director, Alkemists Pharmaceuticals
"A good friend of mine once told me that if you are going to be poor, you might as well be healthy. This reminded me that the industries that tend to survive in tough economic conditions are the ones that provide the essential simple pleasures of life. We go to the movies to forget about our daily problems, and we drink, smoke and gamble in order to cope with our daily lives. Wealth Daily writes, 'Tough economic times won't stop gamblers from gambling, drinkers from drinking, or smokers from smoking. It's not going to happen. In fact, tough economics may give them more reason to indulge in smokes, drinks, and gambling-the catalysts for 'sin' stocks.' As I thought more about my friend's comment, it became clear to me that smoking, drinking and gambling are not as popular as they used to be.
"I believe our industry has the potential to provide many of the simple pleasures that are affordable to everyday consumers. This can be accomplished by stepping up our product offerings to deliver the benefits of health, happiness and affliction independence.
"Izaak Walton once said, 'Look to your health; and if you have it, praise God, and value it next to a good conscience; for health is the second blessing that we mortals are capable of; a blessing that money cannot buy.'"-Paul Paslaski, Market Development Director, Cargill
"Is the omega 3 supplement market recession proof? Who would have thought to ask that question 12 months ago? Consumers taking omega 3 supplements do so because they understand the need for these fatty acids for optimum health and well-being. While we are all likely to feel the recession in our pockets, health and well-being will not be the first on the list to take the hit. I don't believe the omega 3 market is recession proof. However, I do believe it is recession resistant. Spending will tighten, but not at the expense of our health. The growing number of American consumers taking omega 3 supplements do so based on the vast number of clinical papers showing the necessity for these fatty acids to maintain a healthy life. Omega 3s are not a fad; they are vital for optimum health, well-being and happiness."-David Shannon, Sales Director-Health Care, Croda Inc.
"The events of the past several weeks on Wall Street and the procedures set in motion by the federal government are going to have a dampening effect on most sectors of the U.S. economy and indeed the entire world economy. Already we are seeing signs of belt-tightening within the pharmaceutical industry, with layoffs predicted in our leading research oriented companies. This does not bode well for the nutraceutical sector. Even though the credit crunch, which seemed ominous, has receded into the background, the real test is the upcoming shopping season with many retailers already dropping hints of tough times ahead for inventory control and cash flow. The silver lining in this scenario is the 100-day honeymoon traditionally granted to an incumbent new President of the U.S. Cautious optimism and easing credit problems could provide a nice bounce in the first quarter of 2009.
"The nutraceutical industry, however, continues to show its resilience in the middle of this doomsday scenario. The recently concluded Supply Side West show in Las Vegas was very well attended and upbeat. Brisk business was conducted on both days. One minor concern to many in our industry is the proposal being tabled to make obesity a clinical problem. We should vigorously defend against this proposal."-Jith Veeravalli, President, Gencor Pacific
"Safety appeared to be the critical issue this year, much more so c
